| Autor: |
Paul TL Chiam, Dinesh Nair, Yean Teng Lim, Cumaraswamy Sivathasan |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Annals, Academy of Medicine, Singapore, Vol 53, Iss 5, Pp 328-330 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2972-4066 |
| DOI: |
10.47102/annals-acadmedsg.2023413 |
| Popis: |
Percutaneous transcatheter aortic valve implantation (TAVI) has become an established therapy for inoperable patients, for high, intermediate and low surgical-risk patients over 65 years old with severe aortic valve stenosis (AS).1,2 Valve-in-valve (ViV) TAVI is an approved indication for patients with degenerated aortic surgical bioprostheses. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
